BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
JD-SW
09618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -398.52%-72.93M | ---- | -89.55%24.43M | ---- | -55.59%233.87M | ---- | 20.17%526.61M | ---- | 21.29%438.2M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -126.63%-26.69M | ---- | -53.20%-11.78M | ---- | 7.73%-7.69M | ---- | -1.73%-8.33M | ---- | -55.69%-8.19M |
Dividend (income)- adjustment | ---- | ---277K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Investment loss (gain) | ---- | 68.80%-1.21M | ---- | -60.00%-3.89M | ---- | ---2.43M | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | -63.51%1.25M | ---- | 109.65%3.43M | ---- | 18,100.00%1.64M | ---- | -98.88%9K |
Impairment and provisions: | ---- | -98.76%266K | ---- | 196.01%21.49M | ---- | 1,683.78%7.26M | ---- | 217.97%407K | ---- | -64.25%128K |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | --597K | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 103.01%4K | ---- | -704.55%-133K | ---- | -94.59%22K | ---- | 217.97%407K | ---- | -64.25%128K |
-Other impairments and provisions | ---- | -98.75%262K | ---- | 190.49%21.03M | ---- | --7.24M | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | 132.33%2.74M | ---- | -349.63%-8.49M | ---- | -76.83%3.4M | ---- | 77.86%14.67M | ---- | --8.25M |
-Other fair value changes | ---- | 132.33%2.74M | ---- | -349.63%-8.49M | ---- | -76.83%3.4M | ---- | 77.86%14.67M | ---- | --8.25M |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---378K | ---- | ---- | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---378K | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -2.77%28.32M | ---- | 28.34%29.13M | ---- | 39.38%22.7M | ---- | 23.62%16.28M | ---- | 46.19%13.17M |
-Amortization of intangible assets | ---- | -6.59%1.47M | ---- | 23.09%1.58M | ---- | -69.75%1.28M | ---- | 204.45%4.24M | ---- | 279.29%1.39M |
Financial expense | ---- | 3,587.18%1.44M | ---- | -20.41%39K | ---- | -55.45%49K | ---- | -61.94%110K | ---- | -76.73%289K |
Exchange Loss (gain) | ---- | -206.52%-147K | ---- | -87.85%138K | ---- | -95.53%1.14M | ---- | 521.78%25.44M | ---- | 327.53%4.09M |
Special items | ---- | -50.09%4.59M | ---- | -68.53%9.2M | ---- | 739.02%29.23M | ---- | -6,365.75%-4.57M | ---- | -78.27%73K |
Operating profit before the change of operating capital | ---- | -203.84%-63.89M | ---- | -78.83%61.53M | ---- | -49.22%290.58M | ---- | 25.49%572.25M | ---- | 24.61%456.03M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | ---- | -116.59%-722K | ---- | --4.35M | ---- | ---- |
Accounts receivable (increase)decrease | ---- | -80.10%22.09M | ---- | 432.31%111.01M | ---- | -265.30%-33.41M | ---- | 121.58%20.21M | ---- | -510.93%-93.66M |
Accounts payable increase (decrease) | ---- | 182.28%11.64M | ---- | -164.49%-14.14M | ---- | 18.17%21.93M | ---- | 105.63%18.56M | ---- | -51.72%9.03M |
Special items for working capital changes | ---- | -194.55%-15.95M | ---- | -153.29%-5.42M | ---- | 152.59%10.16M | ---- | -119.00%-19.33M | ---- | -144.51%-8.83M |
Cash from business operations | -170.97%-116.25M | -130.15%-46.12M | -40.08%-42.9M | -46.98%152.98M | -147.45%-30.63M | -51.59%288.55M | -37.97%64.55M | 64.40%596.04M | -6.05%104.06M | -6.84%362.56M |
Other taxs | 75.53%-23K | -107.39%-165K | 69.68%-94K | 108.63%2.23M | 98.34%-310K | -23.14%-25.89M | 12.12%-18.69M | -0.20%-21.03M | -16.38%-21.27M | 53.50%-20.98M |
Net cash from operations | -170.43%-116.28M | -129.82%-46.29M | -38.98%-43M | -40.91%155.21M | -167.46%-30.94M | -54.32%262.66M | -44.61%45.86M | 68.34%575.02M | -10.49%82.8M | -0.72%341.58M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -36.46%8.56M | 272.72%23.32M | 342.81%13.48M | -1.22%6.26M | --3.04M | -57.79%6.33M | ---- | 153.05%15.01M | ---- | 5.14%5.93M |
Decrease in deposits (increase) | -742.81%-55.74M | 116.66%22.61M | 96.06%-6.61M | -23.39%-135.73M | -144.01%-167.79M | ---110M | ---68.76M | ---- | ---- | ---- |
Sale of fixed assets | -80.71%76K | 1,087.88%392K | --394K | -90.24%33K | ---- | -46.77%338K | ---- | 115.99%635K | ---- | 92.16%294K |
Purchase of fixed assets | 36.82%-1.7M | 90.43%-3.64M | 88.67%-2.7M | 32.74%-38.01M | 50.01%-23.8M | 32.84%-56.51M | -16.65%-47.62M | 11.52%-84.15M | -14.55%-40.83M | -55.24%-95.11M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | -1.74%-6.66M | ---- | ---6.55M | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---19.84M | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 18.66%621.46M | -5.32%878.99M | 35.47%523.73M | 47.57%928.42M | 95.39%386.61M | 59.39%629.12M | 16.39%197.87M | 48.95%394.71M | 47.83%170M | 192.82%265M |
Cash on investment | -31.17%-408.73M | 17.08%-861.56M | 0.07%-311.59M | -25.43%-1.04B | -37.57%-311.81M | -85.04%-828.32M | 17.13%-226.66M | -8.67%-447.65M | -102.60%-273.52M | -357.70%-411.93M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | -97.04%274K | ---- | 156.85%9.26M | ---- |
Net cash from investment operations | -24.35%163.94M | 121.62%60.11M | 290.52%216.71M | 27.88%-278.04M | 21.50%-113.75M | -201.20%-385.54M | -7.27%-144.9M | 45.72%-128M | -159.60%-135.08M | -328.93%-235.82M |
Net cash before financing | -72.56%47.66M | 111.26%13.83M | 220.06%173.71M | 0.05%-122.83M | -46.09%-144.69M | -127.49%-122.89M | -89.42%-99.04M | 322.66%447.01M | -229.22%-52.28M | -63.41%105.76M |
Cash flow from financing activities | ||||||||||
New borrowing | 96.98%77.45M | --158.05M | --39.32M | ---- | ---- | ---- | ---- | ---- | ---- | -87.80%5.29M |
Refund | ---63.59M | ---12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 87.80%-5.29M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --434.01M |
Interest paid - financing | ---- | -66.67%-65K | ---- | 20.41%-39K | ---- | 55.45%-49K | ---- | 70.03%-110K | ---- | 56.67%-367K |
Dividends paid - financing | ---- | 47.16%-118.25M | 47.16%-118.25M | -4.24%-223.81M | -4.24%-223.81M | -7.44%-214.7M | -142.43%-214.7M | -95.36%-199.83M | ---88.56M | ---102.29M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4K |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -131.04%-17.96M | ---- | ---7.77M |
Other items of the financing business | ---5.2M | -3,168.98%-49.43M | ---- | 33.94%-1.51M | 67.18%-578K | 39.04%-2.29M | 68.82%-1.76M | 15.81%-3.76M | 94.48%-5.65M | 96.25%-4.46M |
Net cash from financing operations | 110.97%8.66M | 90.37%-21.7M | 64.82%-78.94M | -3.83%-225.36M | -3.66%-224.39M | 2.08%-217.04M | -129.77%-216.46M | -169.46%-221.65M | 7.91%-94.21M | 358.24%319.12M |
Effect of rate | -76.63%168K | 206.52%147K | 1,992.11%719K | 87.85%-138K | 98.94%-38K | 95.53%-1.14M | -190.03%-3.58M | -521.78%-25.44M | 355.52%3.98M | -327.53%-4.09M |
Net Cash | -40.58%56.32M | 97.74%-7.87M | 125.68%94.78M | -2.43%-348.18M | -16.98%-369.07M | -250.84%-339.92M | -115.37%-315.5M | -46.96%225.36M | -136.89%-146.49M | 156.74%424.89M |
Begining period cash | -1.91%396.22M | -46.30%403.94M | -46.30%403.94M | -31.19%752.26M | -31.19%752.26M | 22.38%1.09B | 22.38%1.09B | 89.04%893.4M | 89.04%893.4M | 54.79%472.61M |
Cash at the end | -9.36%452.7M | -1.91%396.22M | 30.35%499.44M | -46.30%403.94M | -50.51%383.16M | -31.19%752.26M | 3.11%774.24M | 22.38%1.09B | 83.50%750.89M | 89.04%893.4M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.